Sirce II

Background
The U.S. Food and Drug Administration (FDA) is conducting market research to identify qualified vendors capable of supporting the OII Systems for Inspection & Imports, Recalls Compliance, and Enforcement (SIRCE) II initiative. This Request for Information (RFI) is issued solely for market research purposes to assess industry capabilities, capacity, and innovative approaches for delivering comprehensive IT modernization and support services. The goal of this initiative is to leverage effective industry capabilities and innovative approaches available in the marketplace.

Work Details
The FDA aims to gather input on its draft critical Statement of Work (SOW) Task Areas and Technology Stack. The objectives include:

1. Assessing Market Capabilities: Evaluate industry capacity to meet technical and operational requirements.

2. Gathering Industry Feedback: Collect recommendations for improving solicitation approach, evaluation criteria, and technical requirements.

3. Understanding Pricing Approaches: Gain insights into cost structures and performance optimization strategies.

4. Identifying Innovation Opportunities: Explore emerging technologies and best practices that could enhance program outcomes.

The SOW includes critical task areas such as Systems Integration and Engineering Services, which involve developing integration strategies for evolving systems, phasing out legacy systems, and collaborating with other organizations; Architecture Support Services aimed at minimizing development costs while enhancing IT capabilities; and Artificial Intelligence support services focused on integrating AI technologies to enhance regulatory mission capabilities.